Skip to main content
Home

Main navigation

  • Centers & Programs
    • Centers
      • Center for Energy Studies
      • Center for Health and Biosciences
      • Center for the Middle East
      • Center for Public Finance
      • Center for the U.S. and Mexico
      • McNair Center
      Center for Energy Studies
      Providing new insights on the role of economics, policy and regulation in the performance and evolution of energy markets.
      More Details
      The globe at night, lights in populated areas illuminated
      Center for Health and Biosciences
      Advancing data-based policies that promote health and well-being in the U.S. and around the world.
      More Details
      Female healthcare worker lifts finger to press digital buttons featuring topical iconography
      Edward P. Djerejian Center for the Middle East
      Developing pragmatic policy approaches to the region’s enduring political, economic and societal concerns.
      More Details
      Topographic map of Middle East
      Center for Public Finance
      Delivering research and analysis on the effects of major U.S. fiscal policies.
      More Details
      Stack of coins with mathematical figure overlays
      Center for the U.S. and Mexico
      Strengthening the binational relationship by addressing major concerns on both sides of the border.
      More Details
      Textured flags of America and Mexico
      McNair Center for Entrepreneurship and Economic Growth
      Providing actionable policy analysis and recommendations that aim to expand the economy through private enterprise.
      More Details
      Professionals gather around a large table with laptops, printed documents and coffee cups for a business meeting
    • Programs
      • China Studies
      • Drug Policy
      • International Economics
      • Presidential Elections
      • Religion & Public Policy
      • Science & Technology Policy
      • Space Policy
      China Studies
      Analyzing the influence of the transnational circulation of people, technologies, commodities and ideas in China.
      Read More
      Person walks alongside large banner with Chinese characters
      Drug Policy
      Pursuing research and open debate to develop pragmatic drug policies based on common sense and driven by human rights interests.
      Read More
      Marijuana
      International Economics
      Studying timely issues in global economic policy as well as developmental policy in foreign countries.
      Read More
      International paper currencies stacked together, showing range of colors and styles
      Presidential Elections
      Offering nonpartisan analysis of elections to better understand the changing dynamics of presidential campaigns.
      Read More
      An assortment of campaign buttons from a variety of US elections and political pursuits are displayed in a collage
      Religion and Public Policy
      Exploring how religion and cultural factors interact with public policy issues.
      Read More
      A worn path stretches between rows of olive trees
      Science and Technology Policy
      Addressing a broad range of policy issues that affect scientists and their research.
      Read More
      A scientist picks up test tubes from a rack.
      Space Policy
      Focusing on U.S. space policy and the future of space travel.
      Read More
      The International Space Station (ISS) orbits the Earth at sunrise
  • Events
    The front of Baker Hall, from across the plaza, with fountain in foreground
    Center for the U.S. and Mexico
    Thu, Feb. 23, 2023 | 5 pm - 7:30 pm
    Immigration Reform and the Impact on Children: A Town Hall Discussion See Details
  • Experts
    • Biomedical Research
    • Child Health
    • China
    • Conflict Resolution in the Middle East
    • Domestic Health Policy
    • Drug Policy
    • Energy
    • Entrepreneurship and Economic Growth
    • Global Health
    • Health and Biosciences
    • Human Rights and Refugees
    • International Economics
    • Islam and Politics
    • Latin American Energy
    • Middle East
    • Political Economy of the Arab Gulf
    • Presidential Elections
    • Public Finance
    • Religion and Public Policy
    • Science and Technology
    • Space Policy
    • Texas Politics
    • U.S. and Iran
    • U.S. and Mexico
    • See All Experts
    • Experts in the News
  • Support
    • Join the Roundtable
      Join the Roundtable
      Learn more about the Baker Institute’s premier membership forum, which offers unique opportunities to engage with fellows and policy-minded peers.
      Read More
      RT
    • Join the Roundtable Young Professionals
      Join the RT Young Professionals
      If you're interested in major political and public policy issues, and want the opportunity to network with industry leaders and your peers, then our young professionals organization is for you.
      Read More
      RYP Baker
    • Major Gifts
      Major Gifts
      Major gifts provide the funds necessary for the Baker Institute to explore new areas of study and research, and expand current programs.
      Read More
      Wallace S. Wilson meeting with former British Prime Minister Tony Blair
    • Endowments
      Endowments
      Endowment gifts provide the Baker Institute with permanent resources that support research programs, fellows and scholars.
      Read More
      Pictured from left are William Martin, Katharine Neill Harris, Ambassador Edward Djerejian, Alfred C. Glassell, III, and Pam Lindberg
    • Planned Giving
      Planned Giving

      Plan a gift that will ensure lasting, meaningful support for policy programs important to you.

       

      Read More
      meeting
    • Corporate Support
      Corporate Support
      Corporations can become involved with the institute in a number of ways and see the benefit from the research conducted by our fellows and scholars.
      Read More
      Wide shot of the Doré Commons during a Shell Distinguished Lecture Series event featuring Wim Thomas
  • About
    • People
      People
      Learn more about the Baker Institute's leadership and get contact information for the administrative staff.
      Read More
      Secretary James A. Baker, III, stands with a portion of the Berlin Wall, outside of Baker Hall
    • Student Opportunities
      Student Opportunities
      Through the internships on campus and beyond, Rice students can explore careers in public policy, or simply become better informed about important issues of the day.
      Read More
      Amb. Edward P. Djerejian speaks with students outside Baker Hall
    • Annual Report
    • Blog
    • Contact
      Contact Us
      Complete a form for event, media or other inquiries, and get directions and parking information for the Baker Institute.
      Read More
      The front of Baker Hall, from across the plaza, with fountain in foreground
  • Contact
  • Research
    • Economics & Finance
      Economics & Finance
      Read More
    • Energy
      Latest Energy Research
      Summary on Latest Energy Research
      Read More
    • Foreign Policy
      Foreign Policy
      Read More
    • Domestic Policy
      Domestic Policy
      Read More
    • Health & Science
      Health & Science
      Read More
    • All Publications
  • Facebook
  • Youtube
  • Twitter
  • Linkedin
  • Economics & Finance
  • Energy
  • Foreign Policy
  • Domestic Policy
  • Health & Science
  • All Publications
Center for Health and Biosciences | Biomedical Research | Policy Brief

Improving the Effectiveness of the Annual Flu Vaccine

October 29, 2018 | Michael W. Deem, Melia E. Bonomo, Kirstin R.W. Matthews
A woman sneezes into a tissue.

Table of Contents

Author(s)

Kirstin R.W. Matthews
Fellow in Science and Technology Policy

Share this Publication

  • Facebook
  • Twitter
  • Email
  • Linkedin
  • Download PDF
  • Print This Publication
  • Cite This Publication

    Deem, Michael W., Melia E. Bonomo, and Kirstin R.W. Matthews. 2018. Improving the Effectiveness of the Annual Flu Vaccine. Policy brief no. 10.29.18. Rice University’s Baker Institute for Public Policy, Houston, Texas.

    Copy Citation

Tags

Baker Institutevaccinesdiseases, infectionsvaccinesvaccines

Seasonal influenza (flu) causes 9.3 million to 49.0 million illnesses and 12,000 to 79,000 deaths in the United States annually.1 To combat its impact, the Centers for Disease Control and Prevention (CDC) recommends all healthy children and adults obtain a flu vaccination every year. In 2017-18, 57.9% of healthy children (6 months to 17 years old) obtained the vaccine, and approximately 80% of pediatric deaths from influenza during that season were children who were unvaccinated.2 Vaccinations have been proven to reduce flu-related hospitalizations and severe illness outcomes.3,4

Figure 1 — Flu Vaccination Coverage and Vaccine Effectiveness Against Flu Type A(H3N2) for U.S. Adults

This graph compares A(H3N2) flu vaccination coverage and vaccine effectiveness over time.
Notes  The effectiveness of the flu vaccine against the dominate strain type A(H3N2) varies each year (green line). Further, only 42% of the population obtains a flu vaccine on average (orange bars), although the CDC’s “Healthy People 2020” goal is 70% (blue bar).
*In 2015-16, the flu vaccination effectiveness against type A(H3N2) was -11%, which means that people who received the vaccine were more susceptible to being infected with the A(H3N2) flu virus than people who were unvaccinated.
Source  [Coverage] Centers for Disease Control and Prevention (CDC), https://www.cdc.gov/flu/fluvaxview/coverage-1617estimates.htm; [Effectiveness] Bonomo, M.E., and M.W. Deem. 2018. Clinical Infectious Diseases 67(7): 1129–1131.

One challenge to flu vaccinations is that a new flu vaccine is usually created each year. The flu virus is constantly evolving and changing.5 The genetic material of the viruses is encoded in RNA, an unstable molecule that is characterized by frequent mutations, or random changes to the genome. Because of these genetic changes, the vaccine must be updated almost every flu season.5,6 Predicting the most dominant flu virus strains that will affect people each flu season is a difficult process, as demonstrated by the variability in the effectiveness of flu vaccines (Figure 1).

The majority of flu vaccines are created from three types of deactivated flu viruses: A(H3N2), A(H1N1), and B. The A(H3N2) virus is usually the most dominant and causes the majority of patient illness and death each flu season because it tends to mutate more frequently than the other types.7 Over the past decade, the A(H3N2) vaccine reduced the risk of having to go to the doctor with the flu by 25% (Figure 1).8

To develop a vaccine in time for the beginning of flu season in the fall, scientists must start in early January. The current method that the CDC uses involves scientists vaccinating ferrets with several vaccine candidates. They then extract the antibodies from the ferrets to estimate which vaccine was the most effective against the dominant viruses from the previous flu season. This method has been used for almost 50 years. However, it has been proven to be inconsistent in predicting how well the vaccines would perform in humans, especially with the recent, rapidly mutating A(H3N2) viruses.7-9 Additionally, experiments with ferrets are time-consuming and costly.

In contrast, mathematical models, including a model developed at Rice University over 15 years ago, allow scientists to calculate how well the flu vaccine matches the infecting viruses.10,11 The Rice model, called pEpitope, estimates vaccine effectiveness, and it has been shown to work well for flu A(H3N2), A(H1N1), and B vaccines.8,12,13 For the 2018-19 flu season, Rice scientists predict that the vaccine will be between 20–40% effective against the majority of A(H3N2) viruses. Unfortunately, the model also predicts no protection against a small, newly evolving group of A(H3N2) flu strains. Modeling, if used during the early stages of vaccine development, also helps identify likely vaccine strains and improves the effectiveness of the vaccine.

Recommendations

Public health researchers are often slow to change. Despite the fact that Rice’s pEpitope model has been around for more than 15 years, it is unclear why the CDC has yet to take advantage of it in developing their seasonal flu vaccine.10, 11

Adding such a model to the already existing ferret experiments will enhance the current vaccination decision-making process. This mathematical modeling technique can rapidly narrow down the viruses that would be good candidates for the vaccine during a particular flu season. It can serve as a check to make sure that the vaccine virus does not mutate during the manufacturing process. The pEpitope model is also low-cost, as it does not require any specialized equipment. Finally, it is extremely quick, taking just a couple of seconds to analyze the potential effectiveness of a vaccine against thousands of infecting viruses in a particular geographic region.

The CDC should strengthen their current protocols for choosing vaccine candidates by utilizing all available prediction modeling. This will improve overall flu vaccine effectiveness rates and potentially coverage rates as well. Scientists hope that with improved effectiveness, they will also be able to improve vaccine coverage rates, which still trail behind the CDC’s Healthy People 2020 goal of 70%.14 Given the difficulty in producing effective vaccines and the general climate of public mistrust of immunization, this work has the potential to improve vaccine strain selection and education by providing a tool that is accessible to researchers and citizen scientists alike.

Endnotes

1. Centers for Disease Control and Prevention (CDC). 2018. “Disease Burden of Influenza.” https://www.cdc.gov/flu/about/disease/burden.htm.

2. Centers for Disease Control and Prevention (CDC). 2018. “Cumulative monthly influenza vaccination coverage estimates for children 6 months through 17 years by state, HHS region, and the United States, National Immunization Survey- Flu (NIS-Flu), 2017-18 influenza season.” https://www.cdc.gov/flu/fluvaxview/reportshtml/reporti1718/reporti/index.html.

3. Talbot, H.K., et al. 2013. “Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011–2012 influenza season.” Clinical Infectious Diseases 56(12): 1774–1777.

4. Arriola, C., et al. 2017. “Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza.” Clinical Infectious Diseases 65(8): 1289–1297.

5. Petrova, V.N., and C.A. Russell. 2018. “The evolution of seasonal influenza viruses.” Nature Reviews Microbiology 16(1): 47.

6. Palese, P. 2004. “Influenza: old and new threats.” Nature Medicine 10(12s): S82.

7. Hampson, A., et al. 2017. “Improving the selection and development of influenza vaccine viruses–Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015.” Vaccine 35(8): 1104–1109.

8. Bonomo, M.E., and M.W. Deem. 2018. “Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope.” Clinical Infectious Diseases 67(7): 1129–1131.

9. Barr, I.G., et al. 2010. “Epidemiological, antigenic and genetic characteristics of seasonal influenza A (H1N1), A (H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season.” Vaccine 28(5): 1156–1167.

10. Deem, M.W., and H.Y. Lee. 2003. “Sequence Space Localization in the Immune System Response to Vaccination and Disease.” Physical Review Letters 91: 068101.

11. Morris, D.H., et al. 2018. “Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology." Trends in Microbiology 26(2): 102-118.

12. Pan, K., K.C. Subieta, and M.W. Deem. 2010. “A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains.” Protein Engineering, Design & Selection 24(3): 291–299.

13. Pan, Y., and M.W. Deem. 2016. “Prediction of influenza B vaccine effectiveness from sequence data.” Vaccine 34(38): 4610–4617.

14. Centers for Disease Control and Prevention (CDC). 2018. “Results for General Population Influenza Vaccination Coverage.” https://www.cdc.gov/flu/fluvaxview/interactive-general-population.htm.

 

 

This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s), and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.

© 2018 Rice University’s Baker Institute for Public Policy
  • Print This Publication
  • Share
    • Facebook
    • Twitter
    • Email
    • Linkedin

Related Research

Kidney imaging
Center for Health and Biosciences | Journal

Fifty Years of a National Program for the Treatment of Kidney Failure

Read More
Solider sitting in folding chair
Center for Health and Biosciences | Domestic Health Policy Analysis | Newsletter

Should Health Care Providers Ask Their Regular Patients About Their Sexual Health?

Read More
RX Medicine
Center for Health and Biosciences | Domestic Health Policy Analysis | Commentary

How Mark Cuban's Prescription Drug Disruption Could Save Lives

Read More
  • Facebook
  • Youtube
  • Twitter
  • Linkedin
  • Donate Now
  • Media Inquiries
  • Membership
  • About the Institute
  • Rice.edu
Contact Us

6100 Main Street
Baker Hall MS-40, Suite 120
Houston, TX 77005

Email: bipp@rice.edu
Phone: 713-348-4683
Fax: 713-348-5993

Baker Institute Newsletter

The email newsletter of Rice University's Baker Institute for Public Policy provides a snapshot of institute news, research and upcoming events.

Sign Up

  • © Rice University's Baker Institute for Public Policy
  • Web Accessibility
  • Privacy Policy